DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 04 · Volume 45 · June 2012 DOI: 10.1055/s-002-23307

Original Paper

127
Haueis, P.; Russmann, S.; Zorina, O. I.; Grohmann, R.; Kullak-Ublick, G. A.; Jaquenoud Sirot, E.; Russmann, H.: Coprescription of Levodopa with Antipsychotics in a Population of 84 596 Psychiatric Inpatients from 1994 to 2008
133
Shinfuku, M.; Uchida, H.; Tsutsumi, C.; Suzuki, T.; Watanabe, K.; Kimura, Y.; Tsutsumi, Y.; Ishii, K.; Imasaka, Y.; Mimura, M.; Kapur, S.: How Psychotropic Polypharmacy in Schizophrenia Begins: A Longitudinal Perspective
138
Frasch, K.; Weiser, P.; Becker, T.; Längle, G.; Steinert, T.; Niederreiner, C.; Pfiffner, C.; Jäger, S.; Bayer, W.; Eschweiler, G. W.; Kilian, R.: Psychotropic Drug Treatment, Clinical Characteristics and Cognitive Processing Speed in Patients with Schizophrenia: Results from the ELAN Study
156
Huber, C. G.; Hoppe, A.; Agorastos, A.; Andresen, B.; Naber, D.; Schroeder, K.: Are Ratings on the Positive and Negative Syndrome Scale for Schizophrenia Biased by Personality Traits?

Letter

164